Provided by Tiger Trade Technology Pte. Ltd.

Natera

345.34
-5.4400-1.55%
Post-market: 345.340.00000.00%19:53 EDT
Volume:1.43M
Turnover:498.01M
Market Cap:49.46B
PE:-251.54
High:357.15
Open:350.18
Low:343.28
Close:350.78
52wk High:357.15
52wk Low:157.43
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.33
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:27.15
PE(LYR):-226.18

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares

Reuters
·
Sep 12

UBS Adjusts Price Target on Natera to $435 From $290, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Natera initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Reuters
·
Sep 04

Natera announces publication of new data in Blood Neoplasia on Signatera

TIPRANKS
·
Sep 01

CytoDyn Net Loss Widens to $42.7 Million in FY26

Reuters
·
Aug 31

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

THOMSON REUTERS
·
Aug 28

Natera and Angiex partner in tumor testing using Signatera

TIPRANKS
·
Aug 27

Natera Partners with Angiex to Use Signatera ctDNA Test in Agx101 Phase I Trial Monitoring

Reuters
·
Aug 27

Natera, - Announces Signatera Collaboration with Angiox to Assess Nd-ADC Therapy Response

THOMSON REUTERS
·
Aug 27

Natera, - Collaboration Includes Longitudinal Signatera Ctdna Testing for Agx101 Response Monitoring

THOMSON REUTERS
·
Aug 27

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.
·
Aug 26

Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?

Simply Wall St.
·
Aug 25

Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)

TIPRANKS
·
Aug 24

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)

TIPRANKS
·
Aug 17

Stanley Druckenmiller Ditched These Chip Plays Before the Selloff. Here's How He's Playing the Tech Sector Now.

Dow Jones
·
Aug 17

Natera price target raised to $360 from $290 at Guggenheim

TIPRANKS
·
Aug 17

Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million

Reuters
·
Aug 15

Natera (NTRA) Gets a Buy from Citi

TIPRANKS
·
Aug 14